{"id":8725,"date":"2017-10-26T13:15:32","date_gmt":"2017-10-26T13:15:32","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=8725"},"modified":"2026-07-08T22:00:17","modified_gmt":"2026-07-08T16:30:17","slug":"antibody-drug-conjugates-riding-on-the-second-growth-wave","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/","title":{"rendered":"Antibody Drug Conjugates Market: Riding on the Growth Wave"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">While there are close to 200 ADCs in various&nbsp;stages of development, the market field is currently going through a gradual transition, shifting from relying on conventional technologies to newer approaches for generating ADCs.&nbsp;The <span style=\"text-decoration: underline;\"><strong>\u2018<\/strong><\/span><a href=\"https:\/\/www.rootsanalysis.com\/reports\/antibody-drug-conjugates-market\/270.html\">Antibody Drug Conjugates Market<\/a> (4<sup>th<\/sup> Edition), 2017-2030<span style=\"text-decoration: underline;\">\u2019<\/span> report provides a comprehensive study on the current landscape of ADCs, featuring an elaborate discussion on the future potential of this evolving market.&nbsp; Some of the most interesting insights from our study are presented below.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>A Mushrooming Area For Researchers, Ready For Strong Commercial Growth<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">With more than 10,000 patents filed in the last decade alone, the ADC market continues to garner significant interest within the biopharmaceutical industry.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Promising Clinical Pipeline Offers A Variety Of Novel Opportunities<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The pipeline, featuring product candidates that target various antigens with different warheads, is anticipated to present several opportunities in the near future<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"354\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Antibody-Drug-Conjugates-Clinical-Pipeline-Roots-1.webp\" alt=\"As per Roots Analysis, close to 55% of the antibody drug conjugates are currently in phase I of the clinical pipeline and around 5% have been approved and commercially available in market\" class=\"wp-image-18470\" style=\"object-fit:contain;width:800px;height:420px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Antibody-Drug-Conjugates-Clinical-Pipeline-Roots-1.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Antibody-Drug-Conjugates-Clinical-Pipeline-Roots-1-300x158.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Well-Known Players Have Steadily Driven Innovation<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Innovation in this domain is presently focused on exploring different targets, more potent payloads and stable linkers to tap opportunities across various oncological indications.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Specifically, Novel Conjugation Approaches Have Recently Surfaced<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Several novel conjugation approaches have also been developed and implemented to enhance the stability and therapeutic indices of ADC molecules.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Extensive Clinical Research, Offering Valuable Data Insights, Continues To Hold The Key<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Ongoing improvements in clinical research have revealed better insights on dosing and enabled more efficient MTD estimations.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Led by KOLs from Across the Globe, We Believe The Promise Will Evolve Significantly<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The field has evolved under the guidance of several researchers who have emerged as key opinion leaders.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Venture Capital Funding, As Before, Will Be One Of The Primary Enablers<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Well funded start-ups are actively contributing to drug development efforts while the more established players continue to enhance their offerings through partnerships<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"402\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Antibody-Drug-Conjugates-Venture-Capital-Funding-Roots.webp\" alt=\"Various stakeholders are continuously investing in antibody drug conjugates market. In  past few years over 100 funding instances have been recorded in this field reflecting the growing interest of players\" class=\"wp-image-18471\" style=\"object-fit:contain;width:800px;height:473px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Antibody-Drug-Conjugates-Venture-Capital-Funding-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/Antibody-Drug-Conjugates-Venture-Capital-Funding-Roots-300x179.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Market\u2019s Rapid Growth, Both In The Short-Term And Long-Term\u2026<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Post the approval and launch of multiple late-phase <a href=\"https:\/\/en.wikipedia.org\/wiki\/Antibody-drug_conjugate\">product<\/a> candidates, the market is expected to grow at a rapid pace.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>\u2026 Will Be Driven by Rapid Ongoing Advances<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Advances in payload and linker technologies are likely to result in better opportunities in the long term as more drugs get commercialized for a diverse range of indications<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"381\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/ADCs-Therapeutics-Market-Opportunity-Analysis-Roots.webp\" alt=\"The ADC therapeutics market is fragmented across different segmentations including type of payload, type of linkers, indication and geography. By 2035, ADC conjugates will be majorly used for the treatment of breast cancer\" class=\"wp-image-18472\" style=\"object-fit:contain;width:800px;height:452px\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/ADCs-Therapeutics-Market-Opportunity-Analysis-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/ADCs-Therapeutics-Market-Opportunity-Analysis-Roots-300x170.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Several Stakeholders, Including CMOs, Will Benefit From The Impending Growth Wave<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Well funded start-ups are actively contributing to Antibody Drug development efforts while the more established players continue to enhance their offerings through partnerships.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">To know more please click&nbsp;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/antibody-drug-conjugates-market-4th-edition-2017-2030\/180.html\"><span style=\"text-decoration: underline;\"><strong>Antibody Drug Conjugates Market (4th Edition), 2017-2030<\/strong><\/span><\/a>&nbsp;For any queries \/ suggestions or if you\u2019d like to get access to the full research results, please do not hesitate to contact us at&nbsp;<strong><a href=\"mailto:sales@rootsanalysis.com\">sales@rootsanalysis.com<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>While there are close to 200 ADCs in various&nbsp;stages of development, the market field is currently going through a gradual transition, shifting from relying on conventional technologies to newer approaches for generating ADCs.&nbsp;The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs, featuring an elaborate discussion [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":11943,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58,66,88],"tags":[286],"class_list":["post-8725","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oncology","category-pharmaceuticals","category-therapeutics","tag-antibody-drug"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Antibody Drug Conjugates: Riding on the Second Growth Wave<\/title>\n<meta name=\"description\" content=\"The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antibody Drug Conjugates: Riding on the Second Growth Wave\" \/>\n<meta property=\"og:description\" content=\"The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-26T13:15:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-08T16:30:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/pexels-photo-3683046.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"Antibody Drug Conjugates Market: Riding on the Growth Wave\",\"datePublished\":\"2017-10-26T13:15:32+00:00\",\"dateModified\":\"2026-07-08T16:30:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/\"},\"wordCount\":446,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/pexels-photo-3683046.jpeg\",\"keywords\":[\"Antibody Drug\"],\"articleSection\":[\"Oncology\",\"Pharmaceuticals\",\"Therapeutics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/\",\"name\":\"Antibody Drug Conjugates: Riding on the Second Growth Wave\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/pexels-photo-3683046.jpeg\",\"datePublished\":\"2017-10-26T13:15:32+00:00\",\"dateModified\":\"2026-07-08T16:30:17+00:00\",\"description\":\"The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/pexels-photo-3683046.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/10\\\/pexels-photo-3683046.jpeg\",\"width\":500,\"height\":333,\"caption\":\"Rootsanalysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/antibody-drug-conjugates-riding-on-the-second-growth-wave\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Antibody Drug Conjugates Market: Riding on the Growth Wave\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Antibody Drug Conjugates: Riding on the Second Growth Wave","description":"The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/","og_locale":"en_US","og_type":"article","og_title":"Antibody Drug Conjugates: Riding on the Second Growth Wave","og_description":"The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs..","og_url":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2017-10-26T13:15:32+00:00","article_modified_time":"2026-07-08T16:30:17+00:00","og_image":[{"width":500,"height":333,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/pexels-photo-3683046.jpeg","type":"image\/jpeg"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"Antibody Drug Conjugates Market: Riding on the Growth Wave","datePublished":"2017-10-26T13:15:32+00:00","dateModified":"2026-07-08T16:30:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/"},"wordCount":446,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/pexels-photo-3683046.jpeg","keywords":["Antibody Drug"],"articleSection":["Oncology","Pharmaceuticals","Therapeutics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/","url":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/","name":"Antibody Drug Conjugates: Riding on the Second Growth Wave","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/pexels-photo-3683046.jpeg","datePublished":"2017-10-26T13:15:32+00:00","dateModified":"2026-07-08T16:30:17+00:00","description":"The \u2018Antibody Drug Conjugates Market (4th Edition), 2017-2030\u2019 report provides a comprehensive study on the current landscape of ADCs..","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/pexels-photo-3683046.jpeg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/10\/pexels-photo-3683046.jpeg","width":500,"height":333,"caption":"Rootsanalysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/antibody-drug-conjugates-riding-on-the-second-growth-wave\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Antibody Drug Conjugates Market: Riding on the Growth Wave"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=8725"}],"version-history":[{"count":7,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8725\/revisions"}],"predecessor-version":[{"id":22341,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8725\/revisions\/22341"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/11943"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=8725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=8725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=8725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}